Insider filing · AMLX
Camille L Bedrosian
Chief Medical Officer
profile →
Amylyx Pharmaceuticals, Inc.
AMLX · Healthcare · 20 filings in 24 months
ticker →
Camille L Bedrosian sold $256K of Amylyx Pharmaceuticals (AMLX)
Executed Sep 10, disclosed Sep 14, 4 days later.
Value, as filed
$256K
7,947 sh × $32.21
Executed
Sep 10
the trade date, as filed
Disclosed
Sep 14
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CBCamille L Bedrosian (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Amylyx Pharmaceuticals, Inc. (AMLX). The largest single filing was $256K of AMLX (7,947 sh × $32.21, as filed), executed Sep 10.
The name
AMLXHealthcare · Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for ne…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Camille L Bedrosian in AMLX
AMLXSALE
Amylyx Pharmaceuticals, Inc.
$176K12,039 sh × $14.58
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET